Atreca

+$0.01 (+0.54%) As of 12:17 PM UTC pre-market

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Atreca and other ETFs, options, and stocks.

About BCEL

Atreca, Inc. is a biopharmaceutical company. It develops novel therapeutics and immunotherapies based on a deep understanding of the human immune response.

CEO
John A. Orwin
Employees
134
Headquarters
San Carlos, California
Founded
2010

BCEL Key Statistics

Market cap
71.01M
Price-Earnings ratio
—
Dividend yield
—
Average volume
291.93K
High today
$1.86
Low today
$1.66
Open price
$1.73
Volume
229.27K
52 Week high
$10.73
52 Week low
$1.56

BCEL Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.78 per share
Actual
-$0.65 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure